Course Overview

Print

Comprehensive 2017 Updates for the Prevention, Detection, Diagnosis and Treatment of Infectious Diseases

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven:

  • State-of-the-art approaches to common infectious diseases
  • Guidance for treating highly resistant bacterial infections
  • Clinical approaches to complex, rare and "don't-miss" infectious diseases
  • Zika updates: what you need to know now
  • Care of HIV-infected and other immunocompromised patients
  • Prevention and detection of infections in travelers and immigrants
  • Strategies for optimal decision making in prevention, diagnosis and treatment
  • Systems-based safety and practice improvement

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.  
 

Highlights of the 2017 Program

Expanded Case-Based and Problem-Solving Education 

The 2017 program features an expanded range of interactive, case-based and problem-solving education. The formats are engaging and attendees are encouraged to pose questions in larger sessions as well as one-on-one with the national experts who will be providing updates at this event.

Treating Highly Resistant Bacterial Infections, including:

  • MRSA and vancomycin-intermediate Staph aureus (VISA)
  • Extended spectrum beta-lactamase (ESBL)-producing gram negative rods
  • Carbapenemase-producing  gram negative rods, including the NDM-1 metallo-beta-lactamase-producing organisms
  • Vancomycin-resistant enterococci (VRE) 

Common Infectious Diseases: Updates in Prevention, Diagnosis and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

  • Skin and soft tissue infections
  • Endocarditis, urinary tract infections, C. difficile colitis, and tuberculosis
  • Bone and joint and orthopedic device infections
  • Sexually transmitted infections, including new guidelines
  • Infections in immunocompromised hosts
  • Infections in pregnancy, including Zika
  • Ear, nose and throat (ENT) and eye infections
  • Pneumonia
  • Lyme and other tick-borne diseases
  • HIV infection and its infectious and noninfectious complications
  • PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
  • Vaccinations
  • Hepatitis C

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

  • Zika, Ebola, MERS, and other emerging infectious diseases
  • Infections in travelers and immigrants
  • Zoonoses—the old and the new
  • Re-emergence of vaccine-preventable diseases 
  • Non-tuberculous (“atypical”) mycobacteria

Clinical Decision Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

  • Antimicrobial usage
  • Selecting and utilizing newer diagnostic tests for infectious disease
  • Diagnosing the low-probability but high-impact infections
  • Early detection of life-threatening infections
  • Determining when to hospitalize vs. treat as an outpatient
  • Rational empiric antimicrobial therapy of serious infections: when and how to start, and when to narrow or stop
  • Is it viral or bacterial? Key factors to consider

Safety, Quality, and Practice Improvement

Special sessions on safety, quality, and value added by ID specialists:

  • Antimicrobial stewardship
  • Infection control
  • Early inpatient ID consultations to reduce mortality, length of stay, and costs
  • Outpatient Parenteral Antibiotic Therapy (OPAT): best practices in program design and operation
  • ID for hospital medicine practitioners
  • M. chimaera heater-cooler outbreak update